Maximus vs Foundayo

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Maximus vs Foundayo: Overview

Choosing between Maximus and Foundayo for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Maximus offers both semaglutide and tirzepatide at $150/month with a rating of 8.3/10. Foundayo offers orforglipron at $149/month with a 9.2/10 rating.

With only a $1/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$1/mo
Rating Difference
0.9
Winner
Foundayo
Best For
Budget

Maximus

View full Maximus review →
Rating
8.3/10
Monthly Price
$150
Medications
semaglutidetirzepatide

Pros

  • Offers both compounded and FDA-approved branded GLP-1s, and labels which is which on the landing page: compounded semaglutide from $149.99/mo, compounded tirzepatide from $249.99/mo, and brand-name Ozempic, Mounjaro, Wegovy, Foundayo and Zepbound from $199.99/mo (checked July 27, 2026)
  • Brand-name medication at $199.99 undercuts its own compounded tirzepatide, so the FDA-approved route is not automatically the expensive one here
  • Trustpilot rating of 4.4 across 1,034 reviews
  • This offer is restricted in only two states, Alaska and Washington - the narrowest exclusion list of any provider we have reviewed
  • Substantial free tooling and educational content: BMI and TDEE calculators, a semaglutide versus tirzepatide comparison, and guides on what GLP-1s actually do
  • Testosterone, oxytocin and weight-loss protocols under one roof if you want hormone and metabolic care from the same clinic
  • The body-fat chart carries a 'Results may vary' disclaimer rather than presenting the figure as a promise

Cons

  • The headline result claim is '↓28%' body fat, sourced only to 'Averages based on real results from Maximus clients'. That data is not published, and body fat is a different measure from the body-weight percentages every other provider quotes - the two are easy to confuse when comparing
  • We could not find an explicit 'not FDA-approved' disclosure for the compounded products. The category is labelled 'Compounded' and the other is labelled 'FDA-approved', but the plain statement most competitors make is missing
  • No refund or cancellation policy is published - only a privacy policy and terms of use
  • A statistic on the oxytocin product renders as '↑ 0 %of participants reported', so at least one clinical figure on the page is broken
  • 'Starting at' pricing on all three categories, with no indication of what plan length unlocks the lowest rate
  • GLP-1 sits alongside testosterone and mood products in a men's-focused brand, so the weight-loss programme is one line among several
  • No published phone number or support hours on the landing page
Choose Maximus

Foundayo

View full Foundayo review →
Rating
9.2/10Better
Monthly Price
$149Cheaper
Medications
orforglipron

Pros

  • The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
  • In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
  • Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
  • A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
  • Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
  • Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
  • Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
  • Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
  • It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

  • Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
  • It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
  • Should not be used alongside another GLP-1 receptor agonist
  • Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
  • Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
  • Safety and effectiveness in children have not been established
  • $149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
  • Very new to market, so there is no long-term real-world safety and adherence record yet
Choose Foundayo

Feature-by-feature comparison

FeatureMaximusFoundayo
Monthly Price$150$149
Rating8.3/109.2/10
Medicationssemaglutide, tirzepatideorforglipron
Insurance AcceptedNoYes
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedNot publishedFree home delivery via LillyDirect; shipping began 6 April 2026
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyNot publishedAs directed by your prescriber
Money-back GuaranteeNone published - no refund policy exists on the siteNone published; this is a prescription medicine, not a subscription service
Cancellation PolicyNot publishedPrescription-based - stopping treatment is a decision for you and your prescriber

Which should you choose?

Choose Maximus if you:

  • Want more medication options to choose from
  • Value: offers both compounded and fda-approved branded glp-1s, and labels which is which on the landing page: compounded semaglutide from $149.99/mo, compounded tirzepatide from $249.99/mo, and brand-name ozempic, mounjaro, wegovy, foundayo and zepbound from $199.99/mo (checked july 27, 2026)

Choose Foundayo if you:

  • Want to save $1/month with a more affordable option
  • Prefer a higher-rated service (9.2/10 vs 8.3/10)
  • Need insurance coverage for your treatment
  • Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Website previews

Maximus

Maximus website

Foundayo

Foundayo website

Our recommendation

Foundayo comes out ahead with a higher rating of 9.2/10.
Get started with Foundayo

Compare other providers

Compare GLP-1 Brands